Skip to content

Entheon Biomedical Corp.

Recent events

Recent events tied to this brand in public sources.

Back to profile3 entries

  1. 2021

    Entheon completes acquisition of Lobo Genetics

    Entheon completed its acquisition of Lobo Genetics, which became a wholly owned subsidiary of Entheon following an amalgamation.

  2. 2021

    Entheon completes acquisition of HaluGen

    Entheon Biomedical completed its acquisition of all issued and outstanding common shares of HaluGen Life Sciences, making HaluGen a wholly owned subsidiary.

  3. 2020

    Entheon Biomedical closes private placement

    Entheon Biomedical closed a non-brokered private placement for gross proceeds of CAD $3,174,374.25 and allotted and issued 4,232,499 units.